The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer

• Status: Completed
• Trial end date: 2014-06-01

Summary

1. Objective After single dose in healthy adults the capacity of the Group for DW1029M evaluate the pharmacokinetic characteristics.

2. Indication Diabetic kidney disease

3. Efficacy

1. Primary

• AUClast, AUCinf, AUClast/D, AUCinf/D

• Cmax, Cmax/D

2. Secondary

• Tmax, t1/2, CL/F, Vz/F

4. Safety

1. Adverse Event Monitoring

2. V/S, EKG, Laboratory Test, P/E

• Phase: Phase 1

Details

• Lead Sponsor: Dong Wha Pharmaceutical Co. Ltd.